Boston Scientific to Launch Neuromodulation Products in Japan

Medical device company Boston Scientific (NYSE: BSX  ) announced in a press statement Thursday that its subsidiary, Boston Scientific Japan K.K., has agreed with Japanese firm Fukuda Denshi to market and distribute Boston Scientific's Spinal Cord Precision Plus System in Japan.

The Precision Plus System is part of Boston Scientific's neuromodulation division, one of its faster-growing businesses by sales. Japan is the world's second-largest medical device market and, according to the release, Fukuda Denshi already boasts "extensive sales resources" and a distribution infrastructure in the country to market the product.

More than 60,000 patients worldwide are already using the Precision Plus System, according to Boston Scientific. Under the terms of the agreement, Fukuda Denshi will begin distribution on April 1 of this year.


Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2272912, ~/Articles/ArticleHandler.aspx, 10/1/2014 2:43:03 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement